That PRS modifies the risk in PALB2 and CHEK2 mutation carriers supports previous findings suggesting that common genetic variation at least partly explains the widely observed incomplete penetrance of mutations in breast cancer susceptibility genes14–17. This evidence concerns the gene CHEK2 and breast carcinoma.